Physician profile
John E Lassetter
NPI 1477578300
$6,398.19
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,864 · 2020: $1,931 · 2021: $1,528 · 2022: $112 · 2023: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $95.74 · Travel and Lodging: $66.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $95.74 |
| Travel and Lodging | $66.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $2,122.81 | 2021-2023 | |
| Medtronic Vascular, INC. | $1,818.08 | 2019-2020 | |
| Boston Scientific Corporation | $774.93 | 2019-2023 | Mylux Patient Kit With Mobile Device |
| Abiomed | $573.99 | 2019 | |
| Abbott Laboratories | $549.17 | 2019-2023 | Jot Dx, Gallant |
| Biotronik INC. | $282.21 | 2019 | |
| Edwards Lifesciences Corporation | $102.02 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $56.55 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $29.92 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.12 | 2022 | |
| Merck Sharp & Dohme LLC | $21.11 | 2021 | |
| Amarin Pharma, INC. | $15.21 | 2020 | |
| Impulse Dynamics (USA) INC. | $13.43 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lassetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.